South Korea · Delayed Price · Currency is KRW Jeil Pharma Holdings Statistics
Total Valuation
KRX:002620 has a market cap or net worth of KRW 118.20 billion. The enterprise value is 358.03 billion.
| Market Cap | 118.20B |
| Enterprise Value | 358.03B |
Important Dates
The last earnings date was Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:002620 has 15.35 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 15.35M |
| Shares Outstanding | 15.35M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -0.53% |
| Owned by Insiders (%) | 76.13% |
| Owned by Institutions (%) | n/a |
| Float | 2.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 204.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.91, with an EV/FCF ratio of -49.86.
| EV / Earnings | -12.17 |
| EV / Sales | 0.51 |
| EV / EBITDA | 6.91 |
| EV / EBIT | 9.64 |
| EV / FCF | -49.86 |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.15 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | -22.97 |
| Interest Coverage | 4.76 |
Financial Efficiency
Return on equity (ROE) is -2.38% and return on invested capital (ROIC) is 3.75%.
| Return on Equity (ROE) | -2.38% |
| Return on Assets (ROA) | 2.61% |
| Return on Invested Capital (ROIC) | 3.75% |
| Return on Capital Employed (ROCE) | 6.71% |
| Revenue Per Employee | 19.11B |
| Profits Per Employee | -794.93M |
| Employee Count | 37 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 3.72 |
Taxes
In the past 12 months, KRX:002620 has paid 4.53 billion in taxes.
| Income Tax | 4.53B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.41% in the last 52 weeks. The beta is 0.58, so KRX:002620's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -9.41% |
| 50-Day Moving Average | 8,277.20 |
| 200-Day Moving Average | 8,207.95 |
| Relative Strength Index (RSI) | 39.09 |
| Average Volume (20 Days) | 4,455 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:002620 had revenue of KRW 707.15 billion and -29.41 billion in losses. Loss per share was -1,915.24.
| Revenue | 707.15B |
| Gross Profit | 248.04B |
| Operating Income | 36.34B |
| Pretax Income | -6.10B |
| Net Income | -29.41B |
| EBITDA | 51.01B |
| EBIT | 36.34B |
| Loss Per Share | -1,915.24 |
Balance Sheet
The company has 71.52 billion in cash and 164.96 billion in debt, giving a net cash position of -93.43 billion or -6,086.47 per share.
| Cash & Cash Equivalents | 71.52B |
| Total Debt | 164.96B |
| Net Cash | -93.43B |
| Net Cash Per Share | -6,086.47 |
| Equity (Book Value) | 460.63B |
| Book Value Per Share | 20,494.18 |
| Working Capital | 47.12B |
Cash Flow
In the last 12 months, operating cash flow was 577.20 million and capital expenditures -7.76 billion, giving a free cash flow of -7.18 billion.
| Operating Cash Flow | 577.20M |
| Capital Expenditures | -7.76B |
| Free Cash Flow | -7.18B |
| FCF Per Share | -467.73 |
Margins
Gross margin is 35.08%, with operating and profit margins of 5.14% and -4.16%.
| Gross Margin | 35.08% |
| Operating Margin | 5.14% |
| Pretax Margin | -0.86% |
| Profit Margin | -4.16% |
| EBITDA Margin | 7.21% |
| EBIT Margin | 5.14% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.65%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.65% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.60% |
| Earnings Yield | -24.88% |
| FCF Yield | -6.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 17, 2006. It was a forward split with a ratio of 10.
| Last Split Date | Apr 17, 2006 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
KRX:002620 has an Altman Z-Score of 1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.27 |
| Piotroski F-Score | 5 |